about
Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's diseaseBlood alpha-synuclein in agricultural pesticide handlers in central Washington StateProthrombin Kringle-2: A Potential Inflammatory Pathogen in the Parkinsonian Dopaminergic SystemPossible protective action of neurotrophic factors and natural compounds against common neurodegenerative diseasesNovel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson's diseaseFunctional Role of the Disulfide Isomerase ERp57 in Axonal Regenerationn-butylidenephthalide protects against dopaminergic neuron degeneration and α-synuclein accumulation in Caenorhabditis elegans models of Parkinson's diseaseRodent models in neuroscience research: is it a rat race?Toxin-Induced Experimental Models of Learning and Memory ImpairmentAnti-Oxidants in Parkinson's Disease Therapy: A Critical Point of ViewAlpha-synuclein and tau: teammates in neurodegeneration?Quantitative and semi-quantitative measurements of axonal degeneration in tissue and primary neuron culturesOxidative stress and regulation of Pink1 in zebrafish (Danio rerio)Tetraspanin (TSP-17) protects dopaminergic neurons against 6-OHDA-induced neurodegeneration in C. elegansSelenoprotein T Exerts an Essential Oxidoreductase Activity That Protects Dopaminergic Neurons in Mouse Models of Parkinson's DiseaseParkinsonism signs and symptoms in agricultural pesticide handlers in Washington StateNeuroimaging and neuromodulation approaches to study eating behavior and prevent and treat eating disorders and obesitySolving the puzzle of Parkinson's disease using induced pluripotent stem cells.Acrolein acts as a neurotoxin in the nigrostriatal dopaminergic system of rat: involvement of α-synuclein aggregation and programmed cell deathConsiderations on the role of environmental toxins in idiopathic Parkinson's disease pathophysiologyGene-environment interaction models to unmask susceptibility mechanisms in Parkinson's disease.A role for the p75 neurotrophin receptor in axonal degeneration and apoptosis induced by oxidative stressPhotobiomodulation preserves behaviour and midbrain dopaminergic cells from MPTP toxicity: evidence from two mouse strains.Transient transfection of human CDNF gene reduces the 6-hydroxydopamine-induced neuroinflammation in the rat substantia nigraActivation of GSK-3β and caspase-3 occurs in Nigral dopamine neurons during the development of apoptosis activated by a striatal injection of 6-hydroxydopamineImpaired voluntary wheel running behavior in the unilateral 6-hydroxydopamine rat model of Parkinson's disease.Expression of endogenous Mkp1 in 6-OHDA rat models of Parkinson's disease.Changes in neuronal dopamine homeostasis following 1-methyl-4-phenylpyridinium (MPP+) exposure.Are striatal tyrosine hydroxylase interneurons dopaminergic?Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP MiceA novel biomechanical analysis of gait changes in the MPTP mouse model of Parkinson's disease.Quantification of the Metabolic State in Cell-Model of Parkinson's Disease by Fluorescence Lifetime Imaging Microscopy.Genotype and age at Parkinson disease diagnosis.LPS-induced Murine Neuroinflammation Model: Main Features and Suitability for Pre-clinical Assessment of NutraceuticalsFunctional Rescue of Dopaminergic Neuron Loss in Parkinson's Disease Mice After Transplantation of Hematopoietic Stem and Progenitor Cells.Dopamine-dependent compensation maintains motor behavior in mice with developmental ablation of dopaminergic neurons.Astragalus Polysaccharide Suppresses 6-Hydroxydopamine-Induced Neurotoxicity in Caenorhabditis elegans.TracMouse: A computer aided movement analysis script for the mouse inverted horizontal grid testDietary restriction in cerebral bioenergetics and redox stateHeptachlor induced nigral dopaminergic neuronal loss and Parkinsonism-like movement deficits in mice.
P2860
Q21131066-31A9A43D-3479-4799-8FC1-34A62866CF90Q23922069-B1053053-CAC4-49ED-B67D-82A0151412DFQ26738336-62A56705-E452-4D43-B9FD-92C7657EBF63Q27024349-EC11301F-1E9E-40A1-881F-B8469B5A365AQ27301283-64EA89B6-8D10-42CC-A169-409513962527Q27321375-1E6B898B-A8DE-42A4-99B3-71E18DAC0286Q27334018-DFA1EB0D-CAFE-4784-831D-23E0132171BEQ28071614-A34AA1D4-CFCD-4F00-88AD-675CFFBCA883Q28075913-4BD9107C-A85F-41C0-BF4D-1E8DDD3125B8Q28084254-EC3822F8-C94D-401B-831B-C49097BBF6EEQ28250508-45437B9A-E459-4E16-8352-57CE7246DAC5Q28364882-099E047B-76C5-45F4-B329-F749A3541A8BQ28535834-47B04A7E-7DDD-4FBB-9326-21770409315EQ28542478-EE65E0E7-645D-4F4A-8FD6-2DFFA14DF474Q28854286-EC7869D6-FD56-4070-9FDC-94E3AA797CCCQ29508821-177EE378-CD52-43BC-BA91-9692663143CBQ30976676-A081F9C3-06D2-4BF5-9DAF-35316277FE9DQ33358637-0ED0FF29-8BE9-47D6-B75B-AB2A498A43B8Q33555439-EA4C6E45-74E7-49CE-8C1D-A85493911B36Q33603777-BD80CA6B-9654-4AEF-8546-8C8F162A401AQ33872463-BD5FB1BA-8CBC-4DA4-B18C-04ABCB9503A0Q33985200-15D2A5AF-3E4D-41F0-BA1C-217581C89B97Q34636743-89BEBE8D-6EE2-4022-8C7C-C8621C374CB9Q34768987-FD8500E5-4516-4C4E-8579-1BF75A6171C9Q34936413-0E07B7F2-C0F6-4754-AA97-9ADB934022E6Q35133598-5563DAFD-8EF6-43D7-B777-7E25D6439C7FQ35168296-A97E1681-E37E-4500-B45D-5DB1D4A573C3Q35172603-9E9C80AC-7929-426F-ACB6-C14E7F9B3680Q35515685-0EC83DA4-473A-4AE0-A3BF-DA36981B863EQ35951218-4DE1352F-47E1-42C4-BAF0-5DEF78D098D6Q36020733-4FD4D4F8-6107-4386-A90F-A33FDC9D579DQ36499682-D319CA82-31E7-4510-9830-9A3DCBEF5556Q36729049-F865B87D-5771-47BB-AC10-B4C04AAC9C24Q36781712-C57BA265-F4DC-41BC-8C58-2C6AA4BFDF8AQ37034654-1AB37B99-FE7D-43B1-8B00-9DAF5A303818Q37251953-F85DDA9E-9478-40E5-9D7C-3517C0BD8F5FQ37418770-67603E14-FD6E-498B-A561-88D4A63468D7Q37508349-F5493782-E287-47E2-8A5A-366226BE190BQ37587834-81A6762C-BBAA-420E-A461-C653BCEFFC98Q37621012-84747E6D-F12A-4342-8555-5B9E97F0A7A5
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Neurotoxin-based models of Parkinson's disease.
@en
Neurotoxin-based models of Parkinson's disease.
@nl
type
label
Neurotoxin-based models of Parkinson's disease.
@en
Neurotoxin-based models of Parkinson's disease.
@nl
prefLabel
Neurotoxin-based models of Parkinson's disease.
@en
Neurotoxin-based models of Parkinson's disease.
@nl
P1433
P1476
Neurotoxin-based models of Parkinson's disease.
@en
P356
10.1016/J.NEUROSCIENCE.2011.10.057
P407
P577
2011-11-10T00:00:00Z